J. Torres, S. Mehandru, J. Colombel, and L. Peyrin-biroulet, Crohn's disease, Lancet, vol.389, pp.1741-1755, 2017.

R. Ungaro, S. Mehandru, P. B. Allen, L. Peyrin-biroulet, J. Colombel et al., Lancet, vol.389, pp.1756-1770, 2017.

M. Harbord, V. Annese, S. R. Vavricka, M. Allez, M. Barreiro-de-acosta et al., The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease, J. Crohns Colitis, vol.10, pp.239-254, 2016.

S. Bonovas, G. Fiorino, M. Allocca, T. Lytras, A. Tsantes et al., Intravenous Versus Oral Iron for the Treatment of Anemia in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials, Medicine, vol.95, 2016.

A. U. Dignass, C. Gasche, D. Bettenworth, G. Birgegård, S. Danese et al., European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases, J. Crohns Colitis, vol.9, pp.211-222, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01958873

, Archived: Iron Deficiency Anaemia: Assessment, Prevention and Control, p.24, 2020.

C. Gasche, M. C. Lomer, I. Cavill, and G. Weiss, Iron, anaemia, and inflammatory bowel diseases, Gut, vol.53, pp.1190-1197, 2004.
URL : https://hal.archives-ouvertes.fr/hal-01958873

C. W. Wells, S. Lewis, J. R. Barton, and S. Corbett, Effects of changes in hemoglobin level on quality of life and cognitive function in inflammatory bowel disease patients, Inflamm. Bowel Dis, vol.12, pp.123-130, 2006.

Z. Vegh, Z. Kurti, L. Gonczi, P. A. Golovics, B. D. Lovasz et al., Association of extraintestinal manifestations and anaemia with disease outcomes in patients with inflammatory bowel disease, Scand. J. Gastroenterol, vol.51, pp.848-854, 2016.

I. Blumenstein, A. Dignass, S. Vollmer, W. Klemm, S. Weber-mangal et al., Current practice in the diagnosis and management of IBD-associated anaemia and iron deficiency in Germany: The German AnaemIBD Study, J. Crohns Colitis, vol.8, pp.1308-1314, 2014.

J. Stein, P. Bager, R. Befrits, C. Gasche, M. Gudehus et al., Anaemia management in patients with inflammatory bowel disease: Routine practice across nine European countries, Eur. J. Gastroenterol. Hepatol, vol.25, pp.1456-1463, 2013.

A. Abhyankar and A. C. Moss, Iron Replacement in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-analysis, Inflamm. Bowel Dis, vol.21, 1976.

O. H. Nielsen, C. Soendergaard, M. E. Vikner, and G. Weiss, Rational Management of Iron-Deficiency Anaemia in Inflammatory Bowel Disease, Nutrients, vol.10, 2018.

T. W. Lee, M. R. Kolber, R. N. Fedorak, and S. V. Van-zanten, Iron replacement therapy in inflammatory bowel disease patients with iron deficiency anemia: A systematic review and meta-analysis, J Crohns Colitis, vol.6, pp.267-275, 2012.

O. H. Nielsen, M. Ainsworth, M. Coskun, and G. Weiss, Management of Iron-Deficiency Anemia in Inflammatory Bowel Disease: A Systematic Review, Medicine

W. Reinisch, M. Staun, R. K. Tandon, I. Altorjay, A. V. Thillainayagam et al., A randomized, open-label, non-inferiority study of intravenous iron isomaltoside 1,000 (Monofer) compared with oral iron for treatment of anemia in IBD (PROCEED), Am. J. Gastroenterol, vol.108, pp.1877-1888, 2013.

Z. Tolkien, L. Stecher, A. P. Mander, D. I. Pereira, and J. J. Powell, Ferrous sulfate supplementation causes significant gastrointestinal side-effects in adults: A systematic review and meta-analysis, PLoS ONE, vol.10, 2015.

S. Danese, C. Hoffman, S. Vel, M. Greco, H. Szabo et al., Anaemia from a patient perspective in inflammatory bowel disease: Results from the European Federation of Crohn's and Ulcerative Colitis Association's online survey, Eur. J. Gastroenterol. Hepatol, vol.26, pp.1385-1391, 2014.

S. Lugg, F. Beal, P. Nightingale, N. Bhala, and T. Iqbal, Iron treatment and inflammatory bowel disease: What happens in real practice?, J. Crohns Colitis, vol.8, pp.876-880, 2014.

C. Gasche, T. Ahmad, Z. Tulassay, D. C. Baumgart, B. Bokemeyer et al., AEGIS Study Group Ferric maltol is effective in correcting iron deficiency anemia in patients with inflammatory bowel disease: Results from a phase-3 clinical trial program, Inflamm. Bowel Dis, vol.21, pp.579-588, 2015.

C. Schmidt, T. Ahmad, Z. Tulassay, D. C. Baumgart, B. Bokemeyer et al., AEGIS Study Group Ferric maltol therapy for iron deficiency anaemia in patients with inflammatory bowel disease: Long-term extension data from a Phase 3 study, Aliment. Pharmacol. Ther, vol.44, pp.259-270, 2016.

D. Farrell, M. Artom, W. Czuber-dochan, L. P. Jelsness-jørgensen, C. Norton et al., Interventions for fatigue in inflammatory bowel disease, Cochrane Database Syst. Rev, 2020.

F. Cummings, C. Singfield, L. Jones, J. Hickey, I. Beales et al., PWE-013 Feraccru®real world effectiveness study in hospital practice (fresh): An interim analysis, Gut, vol.67, 2018.

P. Oppong, S. Lovato, and A. Akbar, PTU-124 Real world tolerability & efficacy of oral ferric maltol (feraccru) in IBD associated anaemia, Gut, vol.67, pp.252-253, 2018.

S. Howaldt, I. Jacob, M. Sampson, and F. Akriche, P331 Productivity loss in patients with inflammatory bowel disease receiving treatment for iron deficiency anaemia: A comparison of ferric maltol and IV iron, J. Crohns Colitis, vol.14, pp.319-320, 2020.

S. Howaldt, I. Jacob, M. Sampson, and F. Akriche, P567 Impact of oral ferric maltol and IV iron on health-related quality of life in patients with iron deficiency anaemia and inflammatory bowel disease, and relationship with haemoglobin and serum iron, J. Crohns Colitis, vol.14, pp.478-479, 2020.

S. Howaldt, I. Jacob, M. Sampson, and F. Akriche, P685 Healthcare resource use associated with ferric maltol and IV iron treatment for iron deficiency anaemia in patients with inflammatory bowel disease, J. Crohns Colitis, vol.14, 2020.

G. Abbati, F. Incerti, C. Boarini, F. Pileri, D. Bocchi et al., Safety and efficacy of sucrosomial iron in inflammatory bowel disease patients with iron deficiency anemia, Intern. Emerg. Med, vol.14, pp.423-431, 2019.

A. Stallmach and C. Büning, Ferric maltol (ST10): A novel oral iron supplement for the treatment of iron deficiency anemia in inflammatory bowel disease, Expert Opin. Pharmacother, vol.16, pp.2859-2867, 2015.

W. Guan, Z. Ni, Y. Hu, W. Liang, C. Ou et al., Clinical Characteristics of Coronavirus Disease 2019 in China, N. Engl. J. Med, 2020.

, COVID-19 situation reports, p.27, 2020.

S. Danese, M. Cecconi, and A. Spinelli, Management of IBD during the COVID-19 outbreak: Resetting clinical priorities, Nat. Rev. Gastroenterol. Hepatol, vol.2020, pp.253-255

S. Danese, Z. H. Ran, A. Repici, J. Tong, P. Omodei et al., Gastroenterology department operational reorganisation at the time of covid-19 outbreak: An Italian and Chinese experience, Gut, vol.69, pp.981-983, 2020.

S. Kulnigg, L. Teischinger, C. Dejaco, T. Waldhör, and C. Gasche, Rapid recurrence of IBD-associated anemia and iron deficiency after intravenous iron sucrose and erythropoietin treatment, Am. J. Gastroenterol, vol.104, pp.1460-1467, 2009.

, Q&A on Coronaviruses (COVID-19). Available online, p.25, 2020.